title: [Reaferon and interferonogenes in the therapy of acute viral hepatitis B].
abstract: Monotherapy with reaferon (alpha 2-interferon) versus prodigiosan plus ibuprofen combination was investigated in acute viral hepatitis B. The drugs were found to stimulate cellular immunity and to induce a decrease of total serum IgE levels. The effect of prodigiosan combined with ibuprofen proved more pronounced.
authors.forename: M A
authors.initials: MA
authors.lastname: Andreĭchin
authors.forename: A V
authors.initials: AV
authors.lastname: Zmyzgova
authors.forename: A S
authors.initials: AS
authors.lastname: Rudchik
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D004359:Drug Therapy, Combination; D006509:Hepatitis B / Q000097:blood / Q000628:therapy*; D006801:Humans; D007052:Ibuprofen / Q000494:pharmacology / Q000627:therapeutic use; D007370:Interferon Type I / Q000627:therapeutic use*; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D008875:Middle Aged; D011354:Prodigiozan / Q000494:pharmacology / Q000627:therapeutic use; D011994:Recombinant Proteins
chemical_list: D007370:Interferon Type I; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011354:Prodigiozan; D007052:Ibuprofen
vernacular_title: Primenenie reaferona i interferonogenov v terapii ostrogo virusnogo gepatita B.